Cardiac Marker Test Kit

In vitro diagnostic reagent for cardiac biomarker detection. Enables rapid assessment of cardiac function and myocardial injury.

Diagnostic test for high-sensitivity cardiac troponin I (Hs-cTnI) and other cardiac markers. Provides rapid assessment for acute coronary syndrome evaluation.

Rapid diagnostic test for cardiac markers including myocardial infarction indicators. Enables quick assessment of cardiac events in clinical laboratories.

Rapid immunochromatographic assay for qualitative detection of cardiac biomarkers. Point-of-care diagnostic test for cardiovascular event assessment.

IVD kit for detection and quantification of troponin and other cardiac markers. Used for diagnosis and monitoring of myocardial infarction in acute care settings.

In vitro diagnostic test for detection of cardiac-related biomarkers indicating myocardial injury or cardiac function status. Supports cardiovascular risk assessment and acute coronary syndrome evaluation.

A rapid diagnostic test for detecting cardiac markers to assess heart disease and cardiac events. This test provides quick results for emergency cardiac screening.

Rapid immunoassay test kit for cardiac biomarker detection, enabling point-of-care diagnosis of acute myocardial infarction and heart failure. Single-use disposable format delivers results within 10-15 minutes, supporting emergency department triage and risk stratification in acute cardiac care settings.

Quantitative fluorescence immunoassay test panels for cTnI, NT-proBNP, CK-MB, and D-Dimer that provide highly accurate concentration readouts within 15 minutes. Designed to empower chest pain centers with rapid, accurate results crucial for acute myocardial infarction intervention.

A diagnostic test for cardiac risk markers assessment in cardiovascular health evaluation. Detects biomarkers indicative of potential cardiac conditions.

High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.

Cardiac biomarker assay for detection of myocardial infarction and acute coronary syndrome. Supports rapid cardiac risk stratification in emergency settings.